Prabhakaran, Shyam

Symptomatic intracerebral hemorrhage among eligible warfarin-treated patients receiving intravenous tissue plasminogen activator for acute ischemic stroke. [electronic resource] - Archives of neurology May 2010 - 559-63 p. digital

Publication Type: Journal Article; Research Support, N.I.H., Extramural

1538-3687

10.1001/archneurol.2010.25 doi


Acute Disease--therapy
Anticoagulants--adverse effects
Brain Ischemia--drug therapy
Cerebral Arteries--drug effects
Cerebral Hemorrhage--chemically induced
Drug Synergism
Drug Therapy, Combination
Fibrinolytic Agents--adverse effects
Humans
Iatrogenic Disease--prevention & control
Retrospective Studies
Risk Factors
Stroke--drug therapy
Tissue Plasminogen Activator--adverse effects
Warfarin--adverse effects